100 related articles for article (PubMed ID: 28475006)
41. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
42. miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer.
Shi X; Zhan L; Xiao C; Lei Z; Yang H; Wang L; Zhao J; Zhang HT
Oncotarget; 2015 Aug; 6(22):19043-54. PubMed ID: 26189214
[TBL] [Abstract][Full Text] [Related]
43. miR-133a acts as a tumor suppressor in colorectal cancer by targeting eIF4A1.
Li W; Chen A; Xiong L; Chen T; Tao F; Lu Y; He Q; Zhao L; Ou R; Xu Y
Tumour Biol; 2017 May; 39(5):1010428317698389. PubMed ID: 28466778
[TBL] [Abstract][Full Text] [Related]
44. Stathmin 1 is a potential novel oncogene in melanoma.
Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
[TBL] [Abstract][Full Text] [Related]
45. miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1.
Cohen R; Greenberg E; Nemlich Y; Schachter J; Markel G
Oncotarget; 2015 Aug; 6(22):19006-16. PubMed ID: 26158900
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET.
Han C; Zhou Y; An Q; Li F; Li D; Zhang X; Yu Z; Zheng L; Duan Z; Kan Q
Tumour Biol; 2015 Sep; 36(9):6715-23. PubMed ID: 25874496
[TBL] [Abstract][Full Text] [Related]
48. Expression levels of microRNA‑455 and its potential functions by targeting IGF‑1R in melanoma.
Wang H; Yu L; Shan X
Mol Med Rep; 2017 Jun; 15(6):3852-3858. PubMed ID: 28440508
[TBL] [Abstract][Full Text] [Related]
49. miR-596 Modulates Melanoma Growth by Regulating Cell Survival and Death.
Liu SM; Lin CH; Lu J; Lin IY; Tsai MS; Chen MH; Ma N
J Invest Dermatol; 2018 Apr; 138(4):911-921. PubMed ID: 29183729
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma.
Zhao G; Wei Z; Guo Y
Biol Res; 2020 Mar; 53(1):11. PubMed ID: 32169117
[TBL] [Abstract][Full Text] [Related]
51. miR-25 Promotes Melanoma Progression by regulating RNA binding motif protein 47.
Jiang QQ; Liu WB
Med Sci (Paris); 2018 Oct; 34 Focus issue F1():59-65. PubMed ID: 30403177
[TBL] [Abstract][Full Text] [Related]
52. Proteasome beta-4 subunit contributes to the development of melanoma and is regulated by miR-148b.
Zhang X; Lin D; Lin Y; Chen H; Zou M; Zhong S; Yi X; Han S
Tumour Biol; 2017 Jun; 39(6):1010428317705767. PubMed ID: 28656878
[TBL] [Abstract][Full Text] [Related]
53. miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
Luan W; Zhou Z; Zhu Y; Xia Y; Wang J; Xu B
Biochem Biophys Res Commun; 2018 Jan; 495(1):46-52. PubMed ID: 29097210
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-610 inhibits tumor growth of melanoma by targeting LRP6.
Zhang G; Ai D; Yang X; Ji S; Wang Z; Feng S
Oncotarget; 2017 Nov; 8(57):97361-97370. PubMed ID: 29228616
[TBL] [Abstract][Full Text] [Related]
55. Long Noncoding RNA
Yang F; Lei P; Zeng W; Gao J; Wu N
Cancer Manag Res; 2020; 12():3131-3144. PubMed ID: 32440211
[TBL] [Abstract][Full Text] [Related]
56. Effect of IRS4 levels on PI 3-kinase signalling.
Hoxhaj G; Dissanayake K; MacKintosh C
PLoS One; 2013; 8(9):e73327. PubMed ID: 24039912
[TBL] [Abstract][Full Text] [Related]
57. miR-186 suppressed CYLD expression and promoted cell proliferation in human melanoma.
Qiu H; Yuan S; Lu X
Oncol Lett; 2016 Oct; 12(4):2301-2306. PubMed ID: 27698793
[TBL] [Abstract][Full Text] [Related]
58. Mir-302 cluster exhibits tumor suppressor properties on human unrestricted somatic stem cells.
Jamshidi-Adegani F; Langroudi L; Shafiee A; Mohammadi-Sangcheshmeh A; Ardeshirylajimi A; Barzegar M; Azadmanesh K; Naderi M; Arefian E; Soleimani M
Tumour Biol; 2014 Jul; 35(7):6657-64. PubMed ID: 24705778
[TBL] [Abstract][Full Text] [Related]
59. AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression.
Felli N; Errico MC; Pedini F; Petrini M; Puglisi R; Bellenghi M; Boe A; Felicetti F; Mattia G; De Feo A; Bottero L; Tripodo C; Carè A
Oncogene; 2016 Jun; 35(23):3016-26. PubMed ID: 26434590
[TBL] [Abstract][Full Text] [Related]
60. miR-33a is downregulated in melanoma cells and modulates cell proliferation by targeting PCTAIRE1.
Tian F; Wei H; Tian H; Qiu Y; Xu J
Oncol Lett; 2016 Apr; 11(4):2741-2746. PubMed ID: 27073545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
